August 8, 2024
Mad Hedge Biotech and Healthcare Letter August 8, 2024 Fiat Lux Featured Trade: (WHEN A+ PROFITS MEET C-VALUATION) (AMGN), (ABBV), (GILD)
This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 3184 entries already.
Mad Hedge Biotech and Healthcare Letter August 8, 2024 Fiat Lux Featured Trade: (WHEN A+ PROFITS MEET C-VALUATION) (AMGN), (ABBV), (GILD)
It's time we talk about Amgen (AMGN), that biotech giant that's been acting more like a sleepy bear than the roaring lion it once was. Don't get me wrong. I've got a soft spot for Amgen. Having personally witnessed the struggles of cancer survivors who sampled their wares, I can tell you their stuff works.
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
When John identifies a strategic exit point, he will send you an alert with specific trade information on what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Global Market Comments August 8, 2024 Fiat Lux Featured Trade: (THE IDIOT’S GUIDE TO INVESTING), (TSLA), (BYND), (JPM) (TESTIMONIAL)
Until July 1, everyone seemed to have pretty much the same investment strategy. What would you do if I recommended an investment strategy that would cause your accountant to disown you, your inheritance anticipating children to sue you, and your wife to file for divorce? Chances are you would designate all my future mailings as
Mad Hedge Technology Letter August 7, 2024 Fiat Lux Featured Trade: (TECH OUTAGE BITES) (DAL), (MSFT), (CRWD)
Microsoft (MSFT) dishing out blame to Delta Airlines (DAL) is yet another sign that we need a pullback in tech shares or at least some flat lining. Arrogance comes in many forms, but evading accountability is definitely one of them. It almost appears in the past few quarters that tech companies feel they can get
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Legal Disclaimer
There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.
